“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: PP2.1 Immunomodulatory effects of rapamycin in Graft versus Host Disease

€3.03

SKU: product-article-18276 Category: General

Description
Reviews (0)

Description

PP2.1 Immunomodulatory effects of rapamycin in Graft versus Host Disease

Reviews

There are no reviews yet.

Be the first to review “Article: PP2.1 Immunomodulatory effects of rapamycin in Graft versus Host Disease”

You must be logged in to post a review.

Top

Article: PP2.1 Immunomodulatory effects of rapamycin in Graft versus Host Disease

Description

Reviews

Related products

Article: Highlights in gynaecological cancers

Article: Highlights in gynaecological cancers

Article: Highlights in respiratory oncology

Article: INTRODUCTION